You searched for metabolic diseases - Page 9 of 64

In Depth 3 Mar 2023

Let’s Take a Closer Look at 7 Autoimmune Diseases Biotechs are Fighting to Treat

…other rare autoimmune diseases. As more people are diagnosed with rare autoimmune diseases worldwide, developing new treatments could help decrease the toll these conditions take on the quality of life…

March 3, 2023 - 8 minutesmins - By Alexander Burik

Best in Biotech 20 Dec 2021

The Billion-Euro European Biotech Companies in 2022

…on a number of target diseases, including insomnia, hypertension, and rare and autoimmune diseases. In April 2020, Idorsia’s share price went up 14% after the company published positive results for…

December 20, 2021 - 12 minutesmins - By Larissa Warneck-Silvestrin

News and Trends 31 Mar 2025

AstraZeneca bets on Asia: a surge of deals in March amid fraud probe

…macrocyclic peptide drug research and development platform, which is designed to create drugs that could potentially treat chronic diseases, including rare, autoimmune, and metabolic diseases. Macrocyclic peptides are peptides –…

March 31, 2025 - 7 minutesmins - By Roohi Mariam Peter

Opinion 25 Oct 2023

Microbiome: are we ready for third generation live biotherapeutics?

…(GI) infections and conditions, to boosting the potency of immuno-oncology treatments and perhaps in the future, the treatment of central nervous system (CNS) and metabolic diseases. It’s not been an…

October 25, 2023 - 11 minutesmins - By External Contributor

Best in Biotech 17 Nov 2022

The hottest private biotech companies in Canada

…rare metabolic diseases and conditions in the central nervous system. In 2021, Deep Genomics raised one of Canada’s biggest biotech Series C rounds, bagging $180 million. With the help of…

November 17, 2022 - 6 minutesmins - By Jonathan Smith

News and Trends 3 Feb 2023

AI boosts genome editing

…the foreseeable future it will be possible to use prime editing to repair the DNA mutations of common inherited diseases such as sickle cell anemia, cystic fibrosis or metabolic diseases….

February 3, 2023 - 3 minutesmins - By Jim Cornall

Best in Biotech 24 Oct 2023

Seven molecular glue startups looking to stick around in the biotech industry

…cancer, inflammation, metabolic diseases, and other diseases. Degron also predicts and selects potential molecular glue degrader targets by analysis of its in-house collection of chemical and target data, as well…

October 24, 2023 - 9 minutesmins - By Willow Shah-Neville

Best in Biotech 30 Jan 2017

The Shiniest Golden Vertex? 15 Great Biotechs in Cambridge

…with AbbVie, but its technology is also reaching neurodegenerative diseases with its €1B collaboration with Denali (US). Founded in 2011, Mission Therapeutics focuses on diseases associated with the ubiquitin cell…

January 30, 2017 - 8 minutesmins - By Denise Neves Gameiro

News and Trends 16 Jan 2025

Top biotech deals of December 2024

…molecules (PHICS Technology) for metabolic diseases. It works by creating a bond between a kinase enzyme and a particular target in order to inhibit its function. Photys is set to…

January 16, 2025 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 14 Sep 2016

This French Startup brings Gene Therapy to Neurodegenerative Diseases

…Series A to fund its efforts to stop the progression of Huntington’s and Alzheimer’s diseases. BrainVectis spun out of the French Institute for Health and Medical Research (INSERM) after its…

September 14, 2016 - 3 minutesmins - By Evelyn Warner

Startup Scout 13 Sep 2023

PIM kinase inhibition: a Swiss startup’s unique approach to tackling complex autoimmune disorders

A healthy immune system is supposed to defend the body against disease and infection, but in autoimmune diseases, the immune system malfunctions, and instead attacks the body’s healthy cells, tissues,…

September 13, 2023 - 7 minutesmins - By Willow Shah-Neville

In Depth 14 Nov 2017

The World’s Deadliest Diseases: How is Biotech Fighting Them?

…by researchers at the National Reference Center for Human Prion Diseases (NRPE) in Zurich are expected at the end of this year. Deadly diseases are still around worldwide, and this…

November 14, 2017 - 7 minutesmins - By Ute Boronowsky

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Let’s Take a Closer Look at 7 Autoimmune Diseases Biotechs are Fighting to Treat

The Billion-Euro European Biotech Companies in 2022

AstraZeneca bets on Asia: a surge of deals in March amid fraud probe

Microbiome: are we ready for third generation live biotherapeutics?

The hottest private biotech companies in Canada

AI boosts genome editing

Seven molecular glue startups looking to stick around in the biotech industry

The Shiniest Golden Vertex? 15 Great Biotechs in Cambridge

Top biotech deals of December 2024

This French Startup brings Gene Therapy to Neurodegenerative Diseases

PIM kinase inhibition: a Swiss startup’s unique approach to tackling complex autoimmune disorders

The World’s Deadliest Diseases: How is Biotech Fighting Them?

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!